Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

‘Paradoxical’ FDA Recalls Report Credits Industry Collaboration For Improved Quality, But Uncovers Troubling Data About Older Devices

This article was originally published in The Silver Sheet

Executive Summary

Medical devices on the market for more than five years are recalled more often than younger ones, according to a recent FDA 10-year retrospective report on corrections and removals. “There is an intuitive appeal to the argument that devices that come to the market in an early point in their lifespan – say, the first year – are more likely to be subject to recalls, but that is simply not true,” CDRH Office of Compliance Director Steven Silverman says. Other notable report findings: troubles with components and software are the leading causes for most recalls; problems with AEDs, ventilators and infusion pumps have triggered an increase in high-risk class I recalls; and domestic manufacturers recall products at a much greater volume than those outside the United States.

Advertisement

Related Content

2014 Hot Spots: Top 4 Device Quality & Regulatory Topics
2014 Hot Spots: Top 4 Device Quality & Regulatory Topics
Editors' Picks: Six Themes From 2014
From Suppliers To Sloppiness, Experts Offer 5 Theories Why Aging Devices Are Recalled Most
FDA Blames Over-Reporting For Record-High Recall Count In 2013; Looks To Root Causes
FDA Recalls Guidance Seeks To Allay Manufacturer Anxieties About Device Safety Enhancements
CDRH Terminating High-Risk Device Recalls Faster As Class I’s Increase In 2012
Industry Unveils Radiation Therapy Patient Protection Effort At FDA Meeting

Topics

Advertisement
UsernamePublicRestriction

Register

MT036761

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel